A revolutionary STI test developed by UK-based Linear Diagnostics is on track to dramatically reduce the time it takes to ...

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

Harrison, who was 21 at the time, showed neither signs nor symptoms related to the virus, and was in a long-term relationship. Young and carefree, Harrison had rarely given her health a second thought ...

It falls short of a “cure.” For a cure, no HIV can be found in the genetic information in the patient’s cells. Just a short time ago, doctors didn't think that "remission" could happen with ...

Eight patients completed the full duration of the study with four of them showing a reduction in total HIV DNA ranging from 2% to 85%, and four patients experienced an increase of viral load ...

If you’re concerned about a recent exposure, you can add the HIV RNA Early Detection Test, which can detect an HIV transmission as early as 9 to 11 days after exposure. That bumps the cost up to ...

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients.

The assay is intended to help with assessing HIV viral load levels that are used to monitor effectiveness of antiretroviral treatment.

If you've engaged recently in high-risk behavior, an HIV test is a good idea. Get tested for your own sake and for others: HIV is most infectious in the earliest stage. Keep in mind that the body hasn ...

aaSouth African Centre for Epidemiological Modelling and Analysis, Centre for Epidemic Response and Innovation, School for Data Science and Computational Thinking, Stellenbosch University, ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.